All Pharma News
price-trendAsk Us
Ipsen`s CBO is on a $3B mission to get the company `back on the right track`

Ipsen`s CBO is on a $3B mission to get the company `back on the right track`
Nicole DeFeudis ENDPTS
27 Oct 2021
Share Share
Ipsen scraps pivotal trial as partial clinical hold drags on

Ipsen scraps pivotal trial as partial clinical hold drags on
Nick Paul Taylor FIERCE BIOTECH
26 Mar 2020
Share Share
Revenue growth at Ipsen numbs pain of palovarotene calamity

Revenue growth at Ipsen numbs pain of palovarotene calamity
Phil Taylor PMLIVE
14 Feb 2020
Share Share
Ipsen bags Blueprint drug to move deeper into ultra-rare disease

Ipsen bags Blueprint drug to move deeper into ultra-rare disease
Nick Paul Taylor FIERCE BIOTECH
16 Oct 2019
Share Share
Clementia Pharma Obtains Interim Order for Proposed Transaction With Ipsen

Clementia Pharma Obtains Interim Order for Proposed Transaction With Ipsen
PR NEWSWIRE
07 Mar 2019
Share Share
Ipsen buys rare disease group Clementia in $1.3bn deal

Ipsen buys rare disease group Clementia in $1.3bn deal
PRESS RELEASE
26 Feb 2019
Share Share